? PROJECT 2 Age-related hearing loss (presbyacusis) is a common neurodegenerative disorder that can be associated with loss and/or dysfunction of several specialized cell types in the cochlear lateral wall (metabolic presbyacusis) and the auditory nerve (neural presbyacusis). Project 2 of the Clinical Research Center aims to identify critical cellular and molecular mechanisms underlying human metabolic and neural presbyacusis using mouse models and post-mortem human temporal bones from younger and older donors. Dysregulation of microglia/macrophages and the complement cascade, two fundamental elements of the innate immune system, have been shown to play vital roles in several age-related neurodegenerative disorders. Our preliminary studies have revealed that cochlear macrophages may undergo structural and molecular alterations with increasing age, indicative of functional changes, and that these alterations are associated with pathological changes in the cochlear lateral wall microvasculature of aged mice. Sphingosine-1-phosphate (S1P), a lipid signaling molecule, regulates macrophage activity. Preliminary studies of gene expression patterns and age-related macrophage dysfunction in mouse cochlear tissue suggest a link between a reduction in S1P bioavailability with increasing age and macrophage dysfunction in the cochlear lateral wall. In addition, differential gene expression analysis in the mouse auditory nerve has identified major changes with increasing age in the innate immune response and complement cascade pathways. Recent studies of other neurodegenerative disorders have shown that complement dysregulation can lead to demyelination and neural degeneration. Based on these observations, our overarching hypothesis is that age-dependent dysregulation of the cochlear innate immune system contributes to the degeneration of specialized cells in the aging lateral wall and auditory nerve, leading to declines in auditory function consistent with metabolic and neural presbyacusis. Project 2 will 1) determine the relationship between S1P-mediated macrophage dysfunction and strial microvasculature degeneration in the lateral wall of aged mice (Aim 2.1); and 2) elucidate the links between age-related dysregulation of the complement system with degeneration and functional declines in auditory nerve fibers, in particular fibers with low spontaneous rates (Aim 2.2). Animal models of lateral wall and auditory nerve degeneration characterized in Project 2 will also be used to validate genetic and pathophysiology results obtained from human subjects studied in Projects 1, 3, and 4. Comparative studies of the expression patterns of these key immune response regulatory molecules will also be examined in human temporal bones, which are accessed through the Human Subjects Core (Core B). The ability to compare results from animal models, human temporal bones, and human subjects provides an unparalleled opportunity to address questions regarding the specific role of the cochlear macrophage dysfunction and complement regulation in vascular and myelinating glial pathophysiology associated with human presbyacusis.

Public Health Relevance

? PROJECT 2 Loss or abnormal function of the microvasculature in the stria vascularis (specialized small blood vessels) and auditory nerve fibers in the inner ear leads to age-related hearing loss (presbyacusis). Project 2 of the Clinical Research Center investigates how age-related changes in macrophages and inflammatory regulation contribute to the onset and progression of hearing loss. The results may highlight elements of the innate immune system in the cochlea as novel therapeutic targets to prevent or treat age-related hearing loss and other neurodegenerative diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute on Deafness and Other Communication Disorders (NIDCD)
Type
Specialized Center (P50)
Project #
5P50DC000422-32
Application #
10018499
Study Section
Special Emphasis Panel (ZDC1)
Project Start
1997-07-01
Project End
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
32
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29407
Noble, Kenyaria V; Reyzer, Michelle L; Barth, Jeremy L et al. (2018) Use of Proteomic Imaging Coupled With Transcriptomic Analysis to Identify Biomolecules Responsive to Cochlear Injury. Front Mol Neurosci 11:243
Simpson, Annie N; Simpson, Kit N; Dubno, Judy R (2018) Healthcare Costs for Insured Older U.S. Adults with Hearing Loss. J Am Geriatr Soc 66:1546-1552
Lewis, Morag A; Nolan, Lisa S; Cadge, Barbara A et al. (2018) Whole exome sequencing in adult-onset hearing loss reveals a high load of predicted pathogenic variants in known deafness-associated genes and identifies new candidate genes. BMC Med Genomics 11:77
Bologna, William J; Vaden Jr, Kenneth I; Ahlstrom, Jayne B et al. (2018) Age effects on perceptual organization of speech: Contributions of glimpsing, phonemic restoration, and speech segregation. J Acoust Soc Am 144:267
Panganiban, Clarisse H; Barth, Jeremy L; Darbelli, Lama et al. (2018) Noise-induced dysregulation of Quaking RNA binding proteins contributes to auditory nerve demyelination and hearing loss. J Neurosci :
Chiarello, Christine; Vaden Jr, Kenneth I; Eckert, Mark A (2018) Orthographic influence on spoken word identification: Behavioral and fMRI evidence. Neuropsychologia 111:103-111
Harris, Kelly C; Vaden Jr, Kenneth I; McClaskey, Carolyn M et al. (2018) Complementary metrics of human auditory nerve function derived from compound action potentials. J Neurophysiol 119:1019-1028
McRackan, Theodore R; Fabie, Joshua E; Burton, Jane A et al. (2018) Earphone and Aided Word Recognition Differences in Cochlear Implant Candidates. Otol Neurotol 39:e543-e549
Dubno, Judy R (2018) Beyond the audiogram: application of models of auditory fitness for duty to assess communication in the real world. Int J Audiol 57:321-322
McRackan, Theodore R; Clinkscales, William B; Ahlstrom, Jayne B et al. (2018) Factors associated with benefit of active middle ear implants compared to conventional hearing aids. Laryngoscope 128:2133-2138

Showing the most recent 10 out of 135 publications